Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |